OK432-activated natural killer cells enhanced trastuzumab (Herceptin)-mediated antibody-dependent cellular cytotoxicity in patients with advanced cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17201151

Download in:

View as

General Info

PMID
17201151